Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00612313
What this trial is testing

Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse

Who this might be right for
Depression
University of Texas Southwestern Medical Center 144
Early research (Phase 1)Study completedNCT02982941
What this trial is testing

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteosarcoma+3 more
MacroGenics 25
Testing effectiveness (Phase 2)Study completedNCT01650090
What this trial is testing

Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma

Who this might be right for
Pulmonary Relapse of Osteosarcoma
Eleison Pharmaceuticals LLC. 28
Testing effectiveness (Phase 2)Study completedNCT04773782
What this trial is testing

Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

Who this might be right for
Solid Tumor, Unspecified, ChildRelapsed Solid NeoplasmCNS Tumor
Blueprint Medicines Corporation 29
Early research (Phase 1)Looking for participantsNCT03721068
What this trial is testing

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Who this might be right for
NeuroblastomaOsteosarcoma
UNC Lineberger Comprehensive Cancer Center 18
Early research (Phase 1)Study completedNCT03507491
What this trial is testing

Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors

Who this might be right for
Cancer
Emory University 24
Early research (Phase 1)Study completedNCT02444546
What this trial is testing

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Who this might be right for
Childhood AstrocytomaChildhood Atypical Teratoid/Rhabdoid TumorDiffuse Intrinsic Pontine Glioma+7 more
Mayo Clinic 6
Early research (Phase 1)Study completedNCT01077544
What this trial is testing

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04203316
What this trial is testing

Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
Children's Oncology Group 1
Testing effectiveness (Phase 2)Study completedNCT02684058
What this trial is testing

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Who this might be right for
Diffuse AstrocytomaAnaplastic AstrocytomaAstrocytoma+19 more
Novartis Pharmaceuticals 151
Early research (Phase 1)Study completedNCT01858155
What this trial is testing

Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors

Who this might be right for
Relapsed Malignant Solid Tumor
C17 Council 9
Testing effectiveness (Phase 2)Study completedNCT01708174
What this trial is testing

A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)

Who this might be right for
Medulloblastoma
Novartis Pharmaceuticals 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03373097
What this trial is testing

Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors

Who this might be right for
NeuroblastomaNeuroblastoma RecurrentGD2-positive Solid Tumors+3 more
Bambino Gesù Hospital and Research Institute 42
Early research (Phase 1)Looking for participantsNCT05608148
What this trial is testing

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

Who this might be right for
Refractory/Relapse NeuroblastomaPediatric Solid Tumors
Kyushu University 61
Testing effectiveness (Phase 2)Looking for participantsNCT05751044
What this trial is testing

HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more
Princess Maxima Center for Pediatric Oncology
Testing effectiveness (Phase 2)Active Not RecruitingNCT03793478
What this trial is testing

Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood

Who this might be right for
Acute Myeloid Leukemia
Daiichi Sankyo 65
Early research (Phase 1)Ended earlyNCT03515200
What this trial is testing

Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed Remission
St. Jude Children's Research Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00186875
What this trial is testing

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoma, Lymphoblastic
St. Jude Children's Research Hospital 47
Early research (Phase 1)Ended earlyNCT02057289
What this trial is testing

A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis

Who this might be right for
ImmunocompromisedBone Marrow TransplantCancer
Children's Hospital Medical Center, Cincinnati 9
Testing effectiveness (Phase 2)WithdrawnNCT04156659
What this trial is testing

Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
Next Page
26